Tracheobronchopathia Osteochondroplastica
Vivian Leske, Romain Lazor, Daniel Coëtmeur et al. · Medicine · 2001
Introduction Abbreviations used in this article: BMP, bone morphogenic protein, CT, computed tomography, ENT, ear, nose and throat, FEV1, forced expiratory volume in 1 second, FVC, forced vital capacity, PFT, pulmonary function tests, TGF, transforming growth factor, TLC, total lung capacity, TO, tracheobronchopathia osteochondroplastica Tracheobronchopathia osteochondroplastica (TO) is a rare disorder of unknown cause affecting the tracheobronchial tree. It is characterized by the presence of multiple osseous and/or cartilaginous submucosal nodules protruding into the lumen of the trachea and large bronchi, typically sparing the posterior wall. Because of its usually benign course, TO was formerly an incidental finding at autopsy. It is presently increasingly discovered at fiberoptic bronchoscopy and/or chest computed tomography (CT) usually performed for other reasons. The first case of TO was described by Wilks (83) in 1857 under the title of “Ossific Deposits on the Larynx, Trachea and Bronchi,” referring to the autopsy findings in a 38-year-old man who died from tuberculosis. In 1863, Virchow (82) considered TO to be an “ecchondrosis and exostosis” arising from the normal tracheal rings. The entity was named “tracheopathia osteoplastica” in 1910 by Aschoff (4), who considered it to be a disorder of the connective tissue, specifically affecting the internal elastic membrane of the trachea and major bronchi. Later, special interest was directed to the association of TO, atrophic rhinitis, and Klebsiella ozaenae(36,49,62,73), the latter being named after its isolation from patients with ozena, the other designation of atrophic rhinitis (1). Hence, most published clinical papers on TO refer to single cases or small series, the only previous large study being a report of 30 cases published in 1977 (32). The present study was undertaken to characterize better the clinical, functional, imaging, and endoscopic features of TO in a large series of cases, to estimate the rate of disease progression, and to determine its morbidity and mortality. Methods Case recruitment This retrospective multicentric study was undertaken by the Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P), a French group of pulmonary physicians interested in rare (so called “orphan”) pulmonary diseases, and distributed nationwide, especially in university centers. Cases were recruited through the GERM“O”P’s registry of rare pulmonary diseases. Starting from April 1995, participating physicians were requested to report to the registry all cases of selected rare pulmonary diseases, including TO. Records were nominative for patients who gave written consent, and anonymous otherwise. Data were collected by a coordination center based in Lyon, France. Data collection In March 1998, a detailed questionnaire was sent to all physicians who had reported cases of TO to the registry. Questionnaires were completed by reviewing the medical records. Retrieved items included past medical history, occupation, smoking status, symptoms and signs at presentation, laboratory data including markers of phosphate and calcium metabolism, bacteriologic analysis of bronchial washings, pulmonary function tests, treatment, and outcome. A copy of histopathologic reports was requested. Detailed charts were used to retrieve findings at fiberoptic bronchoscopy, based on reports of the procedure. Physicians were asked to evaluate the localization (anterolateral and/or posterior), elevation (mild, moderate, or important), and size of submucosal nodules, as well as the degree of airway obstruction if present. To estimate the concentration of nodules on the mucosa, lesions were classified as “scattered” (few nodules leaving areas of normal mucosa between them), “diffuse” (numerous nodules covering the entire mucosa without spared areas between them) or “confluent” (numerous nodules to the point that fusion occurs). Chest X-rays were evaluated for tracheobronchial stenosis and calcifications, atelectasis, parenchymal and mediastinal opacities, and possible tuberculous sequelae. Chest CT scans were analyzed for the presence and location of submucosal nodules, submucosal calcifications (distinct from calcifications of cartilaginous tracheal rings), tracheal deformity, mediastinal lymph nodes, bronchiectasis, atelectasis, pneumonia, and opacities consistent with possible tuberculous sequelae. Non-numerical variables were retrieved as binary propositions. Dates of all events were recorded. Data collection ended in May 2000. Numerical data were expressed as mean ± standard deviation, unless stated otherwise. Selection of cases The inclusion criterion used in the present series was the presence of typical endoscopic findings of TO consisting of characteristic multiple hard nodules, arising from the submucosa and projecting into the lumen of the tracheobronchial tree (46), with a beaded (60) to stalactitic cave appearance (81). Histopathologic diagnosis of TO was defined as the presence of either cartilage or bone in the submucosa at laryngotracheobronchial biopsies (2,21,37,59). However, histologic proof of TO was not required for inclusion. Data analysis All questionnaires were carefully reviewed. Ventilatory defects on pulmonary function tests were classified as obstructive ventilatory defects when the forced expiratory volume in 1 second/ forced vital capacity (FEV1/FVC) was <70%; as restrictive ventilatory defects when the total lung capacity (TLC) was <80% predicted or FVC was <80% predicted with FEV1/FVC >70%; or as combined ventilatory defects when the TLC was <80% predicted with FEV1/FVC <70% (See Table 3). Severity of obstructive ventilatory defect was further classified as mild (FEV1 >70% predicted), moderate (50% predicted < FEV1 < 70% predicted), or severe (FEV1 < 50% predicted). Evolution of pulmonary function over time was analyzed if 2 or more tests were available at least 1 year apart. Obstructive deterioration wa
Cited by 132 works. doi:10.1097/00005792-200111000-00004
Authors
References
- Bacteriologic Flora of the Lower Respiratory Tract
- The Normal Microbial Flora
- Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis
- Relapsing Polychondritis
- TRACHEOPATHIA CHONDRO‐OSTEOPLASTICA. A CASE ELUCIDATING THE PROBLEMS CONCERNING DEVELOPMENT AND OSSIFICATION OF ELASTIC CARTILAGE
- Endobronchial Tuberculosis Revisited
- Role of active and latent transforming growth factor β in bone formation
- Bone morphogenetic proteins in human bone regeneration
- Amyloidosis of the Lower Respiratory Tract
- Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease